Sheets Smith Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-726	Closed	-$303K	–	405
2024 Q1	$303K	Hold	726	–	–	0.03%	320
2023 Q4	$295K	Buy	+726	New	+$268K	0.04%	289
2020 Q4	–	Sell	-1,904	Closed	-$518K	–	344
2020 Q3	$518K	Buy	+1,904	New	+$525K	0.09%	177
2020 Q2	–	Sell	-2,605	Closed	-$620K	–	290
2020 Q1	$620K	Buy	2,605 +191	+8%	+$43.8K	0.13%	143
2019 Q4	$525K	Buy	+2,414	New	+$489K	0.1%	208
2019 Q2	–	Sell	-4,407	Closed	-$811K	–	333
2019 Q1	$811K	Buy	4,407 +1,235	+39%	+$228K	0.18%	141
2018 Q4	$526K	Sell	3,172 -6	-0.2%	-$1.04K	0.14%	155
2018 Q3	$613K	Buy	+3,178	New	+$566K	0.13%	185
2018 Q2	–	Sell	-4,619	Closed	-$753K	–	336
2018 Q1	$753K	Buy	4,619 +317	+7%	+$51.8K	0.18%	139
2017 Q4	$645K	Buy	4,302 +81	+2%	+$12K	0.15%	167
2017 Q3	$642K	Buy	4,221 +1,748	+71%	+$263K	0.16%	161
2017 Q2	$319K	Buy	+2,473	New	+$298K	0.08%	219